Becker's Healthcare November 29, 2022
The fill rate for Tamiflu, the nation’s most popular flu prescription drug, is nearly 100 percent higher than it was this time last year, but the drugmaker has said it has “sufficient supply.”
The week ending Nov. 26 saw a fill rate of 1.02 percent, according to GoodRx data. Last year at this time, that figure was 0.5 percent.
Tamiflu’s generic, oseltamivir, has been in short supply for weeks, according to the American Society of Health-System Pharmacists’ drug shortage website. The maker of Tamiflu, Roche, told Becker’s that, despite the surge, there is “sufficient supply” of the brand product.
“According to the CDC, flu antiviral...
Today's Sponsors
Today's Sponsor